Skip to content
Wenlo
Sign in

News

Market news

Press releases, earnings reports, SEC filings and insider trades from US large-cap companies, and PR Newswire releases from US-listed companies, newest first, with short AI summaries.

  • 10-QICEIntercontinental Exchange, Inc.

    Quarterly report

    Intercontinental Exchange, Inc. filed its quarterly report for the period ended September 30, 2026. The report details financial condition, results of operations, and share repurchases made during the nine months ended September 30, 2026. It also notes trading plans adopted by executives under Rule 10b5-1.

    Source: SEC EDGAR

  • Press releaseDASHDoorDash, Inc.

    DoorDash to Acquire Instacart to Help Local Stores Win

    DoorDash announced a definitive agreement to acquire Instacart for $65.00 per share, representing an equity value of approximately $17 billion. The transaction consideration will be at least 75% cash, with Instacart stockholders able to elect cash, DoorDash stock, or a combination of both. DoorDash also entered into a debt commitment letter with JPMorgan Chase Bank, N.A. for up to $13.0 billion in connection with the merger.

    Source: SEC EDGAR

  • 8-KUSBU.S. Bancorp

    Current report

    U.S. Bancorp reported that Jodi L. Richard resigned as Vice Chair and Chief Risk Officer on October 23, 2026. The company stated the departure was not due to any disagreement on operations, policies, or practices. Troy W. Remington will serve as interim Chief Risk Officer while a successor is sought.

    Source: SEC EDGAR

  • 10-QCTSHCognizant Technology Solutions Corp.

    Quarterly report

    Cognizant Technology Solutions Corp. filed its quarterly report on Form 10-Q for the period ended September 30, 2026. The company reported share repurchases under its stock repurchase program and updates regarding trading plans adopted by executives. The report also detailed financial results and operations for the period.

    Source: SEC EDGAR

  • 10-QALNYAlnylam Pharmaceuticals, Inc.

    Quarterly report

    Alnylam Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026. The company discussed its financial condition, ongoing commercial operations, and potential risks associated with its product pipeline and commercial products like AMVUTTRA. Management and the Chief Financial Officer evaluated disclosure controls and procedures and concluded they were effective as of September 30, 2026.

    Source: SEC EDGAR

  • Press releaseAMPAmeriprise Financial Inc.

    Ameriprise Financial Reports

    Source: SEC EDGAR

  • Press releaseCDZICadiz, Inc.

    Cadiz Raises $21 Million in Registered Direct Offering

    Source: PR NewswireIndustry UTIIndustry WUTIndustry FINIndustry ENVSubject OFR

  • 8-KALNYAlnylam Pharmaceuticals, Inc.

    Current report

    Alnylam Pharmaceuticals, Inc. filed a current report on October 29, 2026. The company announced its financial results for the quarter ended September 30, 2026. The full text of the press release was furnished as an exhibit.

    Source: SEC EDGAR

  • Press releaseCACICACI International Inc

    CACI Awarded $185 Million U.S. Army Task Order to Advance Expeditionary Power and Mission Readiness

    Source: PR NewswireIndustry AROSubject CON

  • Press releaseSILCSilicom Ltd.

    Silicom Reports Q3 2026 Results

    Source: PR NewswireIndustry HRDIndustry PELIndustry CPRIndustry ECPSubject ERN

Press releases and filings from SEC EDGAR and PR Newswire. AI summaries can miss details: read the original before you act. Not investment advice.